120 results
P
patients with de novo IAs
I/C
systematic review and meta-analysis of existing de novo IA cohorts, initial IAs in the middle cerebral artery
O
de novo IAs
P
idosos
I/C
prevenção de quedas, não-prevenção
O
prevenção de quedas
P
NAFLD, elderly, pre-LT type II diabetes mellitus
I/C
de novo PTMS, other liver diseases
O
cardiovascular disease events
P
pacientes con COVID-19
I/C
inhibidores de la enzima convertidora de angiotensina, bloqueadores del receptor de angiotensina II, placebo o ningún tratamiento
O
efectos sobre la COVID-19
P
144 consecutive patients
I/C
first-line DA and SOFIA 6 F Plus catheter for LVOS, rescue stent-retriever
O
successful recanalization (mTICI 2b-3) rate of 75.7%, global rate for functional independence (90-day mRS 0-2) was 40.3%, mTICI 2b-3 rate was 71.6%, overall mTICI2b-3 rate after DA and rescue therapy was 88.9%, pooled estimate of 45.6% for functional independence, mortality within 90 days of 19%, rate of 5.8% of symptomatic intracranial hemorrhage
P
Lemos CA, Verri FR, de Oliveira Neto OB, Cruz RS, Gomes JML, da Silva Casado BG
I/C
high insertion torque, no intervention
O
dental implant success
P
patients with de novo coronary artery lesions
I/C
drug-coated balloon (DCB) treatment, non-DCB devices (such as plain old balloon angioplasty (POBA), bare-metal stents (BMS), or drug-eluting stents (DES))
O
target lesion revascularization (TLR)
P
mujeres postmenopáusicas
I/C
uso de estrógenos
O
infección del tracto urinario sintomática
P
patients with De Quervain's Disease (DQD)
I/C
therapeutic taping, other physical therapy interventions, ultrasound and exercise, ultrasound and Mulligan Pain Releasing Phenomenon, phonophoresis
O
pain, power grip strength, precision grip strength, function
P
infertile patients, control group
I/C
Autoimmunity, antinuclear antibody (ANA), reproductive failures, fertility
O
increased risk of infertility